Literature DB >> 28263402

Incidence, clinical findings, and survival of hepatosplenic T-cell lymphoma in the United States.

Urshila Durani1, Ronald S Go2,3.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28263402     DOI： 10.1002/ajh.24711

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  2 in total

1.  Tumor Necrosis Factor Inhibitors and the Risk of Cancer among Older Americans with Rheumatoid Arthritis.

Authors:  Monica E D'Arcy; Daniel C Beachler; Ruth M Pfeiffer; Jeffrey R Curtis; Xavier Mariette; Raphaele Seror; Parag Mahale; Donna R Rivera; Elizabeth L Yanik; Eric A Engels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-08-23       Impact factor: 4.090

2.  Successful Bridging Chemotherapy with Gemcitabine, Carboplatin, and Dexamethasone before Unrelated Stem Cell Transplantation for Hepatosplenic T-cell Lymphoma.

Authors:  Marika Okuni; Kimikazu Yakushijin; Keiichiro Uehara; Hiroya Ichikawa; Hirotaka Suto; Akiko Hashimoto; Yasuhiro Tanaka; Isaku Shinzato; Rina Sakai; Yu Mizutani; Shigeki Nagao; Keiji Kurata; Seiji Kakiuchi; Yoshiharu Miyata; Yumiko Inui; Yasuyuki Saito; Shinichiro Kawamoto; Katsuya Yamamoto; Mitsuhiro Ito; Hiroshi Matsuoka; Hironobu Minami
Journal:  Intern Med       Date:  2018-11-19       Impact factor: 1.271
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.